Hydrogen Attenuates Oxidative Damage via NRF2-Mediated Mitophagy after Subarachnoid Hemorrhage

Authors:

Abstract
Aims: Mitochondrial dysfunction is recognized as a central pathological mechanism in subarachnoid hemorrhage (SAH). This study aimed to investigate whether mitophagy serves as a key mechanism by which hydrogen (H 2 ) exerts its antioxidative effects following SAH. Results: Using in vivo (mouse SAH model) and in vitro (HT22 cell SAH model) approaches, we demonstrated that H 2 inhalation significantly improved neurological function and alleviated oxidative stress and apoptosis. Mechanistically, H 2 maintained mitochondrial membrane potential and functional integrity by enhancing phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy. RNA sequencing and functional assays identified nuclear factor erythroid 2-related factor 2 (NRF2) as the key upstream target. H 2 promoted NRF2 nuclear translocation and activated the antioxidant pathway. Dual-luciferase reporter assays further confirmed that NRF2 directly binds to and activates the PINK1 promoter. Pharmacological inhibition of NRF2 (ML385) or mitophagy (Mdivi-1) abolished the protective effects of H 2 , confirming that the NRF2-PINK1/Parkin axis is central to the effect of H 2 . Innovation: The present study clearly establishes the NRF2-PINK1/Parkin axis as a key mechanism underlying the neuroprotective effect of H 2 in SAH. This study connects mitochondrial quality control with endogenous antioxidant systems, suggesting H 2 administration as a potential mitochondrion-targeted clinical intervention. Conclusion: The NRF2-PINK1/Parkin axis is a novel and key mechanism underlying the neuroprotective effect of H 2 in SAH. This finding advances our understanding beyond general antioxidant theories by demonstrating a specific, multistep molecular cascade. H 2 administration is a potential mitochondrion-targeted intervention with strong implications for clinical translation in SAH patients. Antioxid. Redox Signal. 44, 443–463.
Funding Information
  • Nature Science Foundation of Jiangsu Province (BK20220185)
  • Fundings for Clinica Trials from the Affiliated Drum Towel Hospital, Medical School of Nanjing University (2022-LCYJ-MS-34)
  • National Natural Science Foundation of China (82201456)
  • National Natural Science Foundation of China (82471366)

This publication has 45 references indexed in Scilit: